SANA (STOCKS)
Sana Biotechnology, Inc. Common Stock
$3.420000
-0.020000 (-0.58%)
Prev close: $3.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven D. Harr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $926.03M
- Employees
- 194
- P/E (TTM)
- -3.55
- P/B (TTM)
- 5.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.21 | $-0.14 | -0.0745 | -54.98% |
|
Sep 2025 (Q3)
|
$-0.16 | $-0.18 | +0.0235 | +12.81% |
|
Jun 2025 (Q2)
|
$-0.21 | $-0.21 | +0.0010 | +0.47% |
|
Mar 2025 (Q1)
|
$-0.21 | $-0.23 | +0.0242 | +10.33% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $250.32M |
| Research and Development | $131.98M |
| Other Operating Expenses | $118.34M |
| Operating Income/Loss | -$250.32M |
| Income/Loss From Continuing Operations After Tax | -$244.17M |
| Income/Loss From Continuing Operations Before Tax | -$244.17M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$244.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$244.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$244.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.96 |
| Diluted Earnings Per Share | -$0.96 |
| Basic Average Shares | 253,234,000 |
| Diluted Average Shares | 253,234,000 |
| Assets | $416.89M |
| Current Assets | $148.68M |
| Noncurrent Assets | $268.21M |
| Fixed Assets | $26.91M |
| Intangible Assets | $59.20M |
| Other Non-current Assets | $182.11M |
| Liabilities | $256.01M |
| Current Liabilities | $78.73M |
| Accounts Payable | $1.67M |
| Wages | $13.24M |
| Other Current Liabilities | $63.82M |
| Noncurrent Liabilities | $177.28M |
| Equity | $160.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $160.88M |
| Liabilities And Equity | $416.89M |
| Net Cash Flow From Operating Activities | -$143.83M |
| Net Cash Flow From Operating Activities, Continuing | -$143.83M |
| Net Cash Flow From Investing Activities | -$40.24M |
| Net Cash Flow From Investing Activities, Continuing | -$40.24M |
| Net Cash Flow From Financing Activities | $128.73M |
| Net Cash Flow From Financing Activities, Continuing | $128.73M |
| Net Cash Flow | -$55.33M |
| Net Cash Flow, Continuing | -$55.33M |
| Comprehensive Income/Loss | -$244.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$244.15M |
| Other Comprehensive Income/Loss | $14.00K |